Teva Pharmaceutical Industries TEVA
NYSE TEVA
$37.34 +0.53 (+1.44%)
At close: Aug 21, 2026 · 4:00 PM EDT

Teva Pharmaceutical Industries (TEVA) Liabilities from Discontinued Operations (2017)

Teva Pharmaceutical Industries' (TEVA) quarterly Liabilities from Discontinued Operations came in at 38000000.0 in Q4 2017.

Teva Pharmaceutical Industries (TEVA) Liabilities from Discontinued Operations (2017) Analysis & Trends

Teva Pharmaceutical Industries (TEVA) has 1 years of Liabilities from Discontinued Operations data on file, last reported at 38000000.0 in Q4 2017.

  • Quarterly Liabilities from Discontinued Operations changed N/A year-over-year to 38000000.0 in Q4 2017, while the trailing twelve-month figure through Dec 2017 was 38000000.0 (changed N/A YoY) and the FY2017 annual result came in at 38000000.0, changed N/A from the prior year.
  • Liabilities from Discontinued Operations was little changed at 38000000.0 in Q4 2017.
  • In the past five years, Liabilities from Discontinued Operations ranged from a high of 38000000.0 in Q4 2017 to a low of 38000000.0 in Q4 2017.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 44.51 Bn 43.55 Bn -
2 Teva Pharmaceutical Industries 43.52 Bn 39.86 Bn 2.15 Bn
3 Zoetis 32.43 Bn 30.75 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn
5 United Therapeutics 21.87 Bn 19.21 Bn 683.80 Mn
6 Viatris 18.98 Bn 18.09 Bn 1.46 Bn
7 Neurocrine Biosciences 15.43 Bn 15.04 Bn 935.80 Mn
8 Elanco Animal Health 12.02 Bn 11.49 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn -
10 Alkermes 8.07 Bn 7.41 Bn 397.90 Mn

Historic Data

Download Data
DateValue
Dec 31, 2017 38.00 Mn
Dec 31, 2017 38.00 Mn